Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.

Berry N, Pradhan S, Sagar R, Gupta SK.

Pharmacotherapy. 2003 Feb;23(2):255-9. Review.

PMID:
12587815
2.

Neuroleptic malignant syndrome associated with olanzapine.

Filice GA, McDougall BC, Ercan-Fang N, Billington CJ.

Ann Pharmacother. 1998 Nov;32(11):1158-9.

PMID:
9825080
3.

Neuroleptic malignant syndrome due to olanzapine.

Hall KL, Taylor WH, Ware MR.

Psychopharmacol Bull. 2001 Summer;35(3):49-54.

PMID:
12397878
4.

Neuroleptic malignant syndrome associated with olanzapine.

Johnson V, Bruxner G.

Aust N Z J Psychiatry. 1998 Dec;32(6):884-6.

PMID:
10084355
5.

Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.

Järventausta K, Leinonen E.

Acta Psychiatr Scand. 2000 Sep;102(3):231-3.

PMID:
11008860
6.

Olanzapine usage associated with neuroleptic malignant syndrome.

Philibert RA, Adam LA, Frank FM, Carney-Doebbeling C.

Psychosomatics. 2001 Nov-Dec;42(6):528-9. No abstract available.

PMID:
11815691
7.

Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.

Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shahda M.

W V Med J. 2002 Mar-Apr;98(2):63-5. Review.

PMID:
12048741
8.

[Neuroleptic malignant syndrome after treatment with olanzapine].

Emborg C.

Ugeskr Laeger. 1999 Mar 8;161(10):1424-5. Danish.

PMID:
10085753
9.

Olanzapine induced neuroleptic malignant syndrome--a case review.

Kogoj A, Velikonja I.

Hum Psychopharmacol. 2003 Jun;18(4):301-9. Review.

PMID:
12766935
10.

Recurrence of neuroleptic malignant syndrome with olanzapine treatment.

Gheorghiu S, Knobler HY, Drumer D.

Am J Psychiatry. 1999 Nov;156(11):1836. No abstract available.

PMID:
10553758
11.

Recurrence of neuroleptic malignant syndrome.

Susman VL, Addonizio G.

J Nerv Ment Dis. 1988 Apr;176(4):234-41. Review.

PMID:
2895164
12.

[Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].

Hanel RA, Sandmann MC, Kranich M, De Bittencourt PR.

Arq Neuropsiquiatr. 1998 Dec;56(4):833-7. Portuguese.

PMID:
10029891
13.

[Neuroleptic malignant syndrome in a patient treated with olanzapine].

Horni G, Meirik K, Lund MB.

Tidsskr Nor Laegeforen. 2003 Oct 23;123(20):2867-9. Norwegian.

14.

Neuroleptic malignant syndrome and low-dose olanzapine.

Suh H, Bronson B, Martin R.

Am J Psychiatry. 2003 Apr;160(4):796. No abstract available.

PMID:
12668376
15.

[Life threatening neuroleptic malignant syndrome due to olanzapine].

Kopf A, Köster J, Schulz A, Krömker H, Becker T.

Psychiatr Prax. 2003 Jul;30(5):279-82. Review. German.

PMID:
12872187
16.

Olanzapine induced neuroleptic malignant syndrome.

Patra BN, Khandelwal SK, Sood M.

Indian J Pharmacol. 2013 Jan-Feb;45(1):98-9. doi: 10.4103/0253-7613.106448.

17.

Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.

Stevens DL, Lee MR, Padua Y.

Pharmacotherapy. 2008 Mar;28(3):403-5. doi: 10.1592/phco.28.3.403.

PMID:
18294120
18.

Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.

Stanfield SC, Privette T.

J Emerg Med. 2000 Nov;19(4):355-7.

PMID:
11074330
19.

Possible neuroleptic malignant syndrome associated with olanzapine.

Nyfort-Hansen K, Alderman CP.

Ann Pharmacother. 2000 May;34(5):667. No abstract available.

PMID:
10852098
20.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460

Supplemental Content

Support Center